Jogitha Selvarajah

Statistics

Publications

Citations

238

H-Index

Active since

2013

Affiliations

St George's, University of London(Current)

King's College London

Novartis (Switzerland)

Novartis (United States)

Piramal (India)

Jogitha Selvarajah is an author at St George's, University of London specializing in oncology, antibiotic resistance mechanisms, and molecular oncology.

Publications per year

2013–2021

Publications

DNA damage-induced S and G2/M cell cycle arrest requires mTORC2-dependent regulation of Chk1

Jogitha Selvarajah, Androulla Elia, Veronica A. Carroll et al. · Oncotarget · 2014 · 68 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Structure of a quinolone-stabilized cleavage complex of topoisomerase IV from<i>Klebsiella pneumoniae</i>and comparison with a related<i>Streptococcus pneumoniae</i>complex

Dennis A. Veselkov, Ivan Laponogov, Xiao-Su Pan et al. · Acta Crystallographica Section D Structural Biology · 2016 · 42 citations · Full text

Life Sciences, Microbiology, Molecular Biology +15

Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria

Colin K. Skepper, Duncan Armstrong, Carl J. Balibar et al. · Journal of Medicinal Chemistry · 2020 · 38 citations · Full text

Life Sciences, Medicinal Chemistry, Microbiology +17

Chemotherapy-mediated p53-dependent DNA damage response in clear cell renal cell carcinoma: role of the mTORC1/2 and hypoxia-inducible factor pathways

Jogitha Selvarajah, K Nathawat, Abdeladim Moumen et al. · Cell Death and Disease · 2013 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive Bacteria

Guillaume Lapointe, Colin K. Skepper, Lauren M. Holder et al. · Journal of Medicinal Chemistry · 2021 · 31 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

1–5 of 6